Abstract
We recently found a gene signature for multiple sclerosis (MS) that reverted to normal during pregnancy in MS patients and included NR4A2 and TNFAIP3, key molecules in anti-inflammatory processes. Here we focus on the expression levels of these two genes in monocytes and CD4+ T cells from healthy controls and treatment-naïve RRMS patients. Our findings show that monocytes play a key role in the dysregulated anti-inflammatory response, being the expression of both genes down-regulated in these cells in RRMS patients with respect to healthy individuals. CD4+ T cells seem to have only a marginal part, because we can observe only a slight down-regulation in NR4A2.
Keywords:
CD4+ T cells; Monocytes; Multiple sclerosis; NR4A2; TNFAIP3.
Copyright © 2014 Elsevier B.V. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
CD4-Positive T-Lymphocytes / metabolism*
-
DNA-Binding Proteins / genetics
-
DNA-Binding Proteins / metabolism*
-
Disability Evaluation
-
Female
-
Gene Expression Regulation / physiology*
-
Humans
-
Intracellular Signaling Peptides and Proteins / genetics
-
Intracellular Signaling Peptides and Proteins / metabolism*
-
Male
-
Middle Aged
-
Monocytes / metabolism*
-
Multiple Sclerosis / pathology*
-
Nuclear Proteins / genetics
-
Nuclear Proteins / metabolism*
-
Nuclear Receptor Subfamily 4, Group A, Member 2 / genetics
-
Nuclear Receptor Subfamily 4, Group A, Member 2 / metabolism*
-
RNA, Messenger / metabolism
-
Statistics, Nonparametric
-
Tumor Necrosis Factor alpha-Induced Protein 3
-
Young Adult
Substances
-
DNA-Binding Proteins
-
Intracellular Signaling Peptides and Proteins
-
NR4A2 protein, human
-
Nuclear Proteins
-
Nuclear Receptor Subfamily 4, Group A, Member 2
-
RNA, Messenger
-
TNFAIP3 protein, human
-
Tumor Necrosis Factor alpha-Induced Protein 3